| Great Plains Rehabilitation Service | |
| 584 12th St W, Dickinson, North Dakota 58601 | |
| (701) 456-4364 |
| Name | Great Plains Rehabilitation Service |
|---|---|
| Organization Name | St Alexius Medical Center |
| Location | 584 12th St W, Dickinson, North Dakota 58601 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (701) 456-4364 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 3 days ago
| NPI Number | 1124051230 |
| Organization Name | ST JOSEPHS HOSPITAL AND HEALTH CENTER |
| Doing Business As | CATHOLIC HEALTH INITIATIVES |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 584 12th St W, Dickinson, ND 58601 |
| Phone Number | 701-456-4364 |
News Archive
The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 3 days ago
| NPI Number | 1356537419 |
| Organization Name | ST JOSEPH'S HOSPITAL & HEALTH CENTER-MEDQUEST |
| Type | DME Supplier - Parenteral & Enteral Nutrition |
| Address | 584 12th St W, Dickinson, ND 58601 |
| Phone Number | 701-456-4364 |
News Archive
The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 3 days ago
| NPI Number | 1518646520 |
| Organization Name | GREAT PLAINS RESTORATIVE SERVICES, LLC |
| Type | DME Supplier - Customized Equipment |
| Address | 584 12th St W, Dickinson, ND 58601 |
| Phone Number | 701-456-4364 |
News Archive
The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 3 days ago
| NPI Number | 1639561434 |
| Organization Name | ST. ALEXIUS MEDICAL CENTER |
| Doing Business As | GREAT PLAINS REHABILITATION SERVICES |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 584 12th St W, Dickinson, ND 58601 |
| Phone Number | 701-456-4364 |
News Archive
The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 3 days ago
News Archive
The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.
A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.
An industry-first technology developed by Loughborough University has the potential to significantly cut nitrogen oxide (NOx) emissions in diesel engines.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 3 days ago
Thrifty White Pharmacy #078 Type: Pharmacy Location: 506 W Villard St, Dickinson, North Dakota 58601 Phone: (701) 227-0191 | |
Clinic Pharmacy Type: Pharmacy Location: 2615 Fairway St, Dickinson, North Dakota 58601 Phone: (701) 483-4401 | |
Irsfeld Pharmacy Pc Type: Community/Retail Pharmacy Location: 33 9th St W, Dickinson, North Dakota 58601 Phone: (701) 483-4858 | |
Nd Pharmacy Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1761 3rd Ave W, Dickinson, North Dakota 58601 Phone: (701) 225-4434 | |
Medicine Shoppe Type: Pharmacy Location: 1571 W Villard, Dickinson, North Dakota 58601 Phone: (701) 227-8265 |